Wu X, Gu Q, Su Y
Nanjing Jinling Hospital.
Zhonghua Fu Chan Ke Za Zhi. 1997 Aug;32(8):489-91.
To evaluate the altered dopaminergic modulation of growth hormone (GH) and prolactin (PRL) in polycystic ovarian syndrome (PCOS).
Responses of GH and PRL to L-Dopa (L-DA) (500 mg) were observed in two PCOS groups (LH/FSH > or = 3, Group I, n = 15, LH/FSH < 3, Group II, n = 15) and the control (n = 20).
Significantly lower GH (P < 0.01) and higher PRL levels (P < 0.05 in group I) in the basal state, and lower responses of GH and PRL to L-DA were found in two PCOS groups as compared with the control.
The altered basal levels and blunted L-DA evoked responses of GH and PRL suggest a relative decrease of the dopaminergic activity in PCOS patients.
评估多囊卵巢综合征(PCOS)患者生长激素(GH)和催乳素(PRL)多巴胺能调节的改变。
观察两组PCOS患者(LH/FSH≥3,I组,n = 15;LH/FSH<3,II组,n = 15)及对照组(n = 20)的GH和PRL对左旋多巴(L-DA)(500mg)的反应。
与对照组相比,两个PCOS组基础状态下GH水平显著降低(P<0.01),I组PRL水平升高(P<0.05),且GH和PRL对L-DA的反应降低。
GH和PRL基础水平的改变以及L-DA诱发反应的减弱表明PCOS患者多巴胺能活性相对降低。